SciHub
文献互助
期刊查询
一搜即达
科研导航
即时热点
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
直率天亦
Lv2
140 积分
2023-11-26 加入
最近求助
最近应助
互助留言
Effects of mirror therapy on phantom limb sensation and phantom limb pain in amputees: A systematic review and meta-analysis of randomized controlled trials
1个月前
已完结
Amivantamab plus lazertinib vs osimertinib in first-line EGFR-mutant advanced non-small cell lung cancer (NSCLC) with biomarkers of high-risk disease: A secondary analysis from the phase 3 MARIPOSA study
2个月前
已关闭
What is the optimal first-line regimen for advanced non-small cell lung cancer patients with epidermal growth factor receptor mutation: a systematic review and network meta-analysis
2个月前
已完结
Sex Differences in Hazard Ratio During Drug Treatment of Non–small-cell Lung Cancer in Major Clinical Trials: A Focused Data Review and Meta-analysis
2个月前
已完结
Cutaneous toxicities associated with epidermal growth factor receptor (EGFR) and mesenchymal epithelial transition factor (MET) dual blockade via bispecific antibody amivantamab
2个月前
已完结
Molecular and Clinical Features of EGFR-TKI-Associated Lung Injury
2个月前
已完结
Advanced non-small-cell lung cancer: how to manage EGFR and HER2 exon 20 insertion mutation-positive disease
2个月前
已完结
Safety study on adverse events of zanubrutinib based on WHO-VigiAccess and FAERS databases
2个月前
已完结
Gender differences in adverse events related to Osimertinib: a real-world pharmacovigilance analysis of FDA adverse event reporting system
2个月前
已完结
Real-world pharmacovigilance analysis unveils the toxicity profile of amivantamab targeting EGFR exon 20 insertion mutations in non-small cell lung cancer
2个月前
已完结
没有进行任何应助
不需要了【积分已退回】
2个月前
不需要了,信息有误【积分已退回】
1年前
标题错误
1年前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论